Gordon R. Penman
Gordon R. Penman
Gordon R. Penman
Gordon Penman has spent his entire legal career at Brown Rudnick representing public and private corporations, entrepreneurs, and funds in a wide array of transactions. He is a versatile legal advisor. His practice spans a wide spectrum of client types and activities. Gordon works with foreign and domestic clients in connection with the acquisition and disposition of public and private targets in transactions valued up to $1 billion. He also advises start-up entities and entrepreneurs seeking to raise their first round of financing.
Gordon has structured numerous types of acquisitions. These include auctions; LBOs; acquisitions and dispositions of product lines, divisions and businesses; and cross-border transactions. He has extensive experience representing companies and investors in venture capital and private equity transactions. Across these activities, his industry experience includes high tech, biotechnology and healthcare, manufacturing and services, financial services, and marketing services.
During the past few years, Gordon has spent a great deal of time assisting clients in restructuring their businesses to address the challenging economics of the “new normal” environment. He has also been involved in several large business disputes and worked extensively with the Firm’s litigation practice to bring these disputes to successful outcomes.
As part of Brown Rudnick’s Family Office team, Gordon is also part of collaborative, cross-disciplinary initiatives assisting clients in this area.
During his tenure with the Firm, Gordon has served in various management capacities including Chair of the Corporate Department, Hiring Committee and Summer Associate Committee as well as a member of the Firm’s Management Committee. Gordon is also a Managing Director of the Venture Capital Fund of New England.
- Representation of a chain of privately owned nursing homes and long-term care facilities in their sale to a public entity structured to take advantage of a unique long-term tax deferral opportunity that increased the value of the transaction to the client by more than 200%.
- Representation of an SBIC venture fund in all of its investments with primary responsibility for structuring the terms of each investment and disposition.
- Representation of a venture fund and its investors in a secondary sale transaction to a new entity that included both existing and new investors.
- Acquisition of a division of a Fortune 100 company by a public foreign corporation, in order to establish its first U.S. operating subsidiary, and numerous follow-on acquisitions.
- Numerous sales of private companies to Fortune 100 corporations.
- Recapitalization of a privately held company involving a $30 million venture capital investment and its subsequent sale two years later for more than $100 million to a Fortune 100 company.
- Representation of various biotechnology companies in both inbound and outbound licensing of technology and numerous venture capital financings.
- Representation of a foreign entity in its bid for a $4 billion division of a Fortune 100 company and in subsequent disputes with its joint venture partner concerning that acquisition.
- Representation of numerous start-up entities in high tech, biotech, medical device, financial services, and marketing services.
- "The Intersection of Two Perspectives: The Lawyer & The VC," The Venture Capital Legal Handbook: Industry Insiders on the Laws and Documents that Govern VC Deals, Raising Capital, Mergers & Acquisitions, April 1, 2004
- American Bar Association
- Massachusetts Bar Association
- Rhode Island Bar Association
- Boston Bar Association
- Rhode Island